11:04 AM EDT, 04/13/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts began the week little changed late Monday morning, edging 0.02% higher to 1,822.16 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and telecommunications company Nokia ( NOK ) , which advanced 26% and 9.3%, respectively. They were followed by furniture maker Natuzzi (NTZ) and biotech firm Evaxion ( EVAX ) , which climbed 7.1% and 3.4%, respectively.

The decliners from continental Europe were led by accommodations booking company trivago (TRVG) and brewing company Anheuser-Busch InBev ( BUD ) , which dropped 3.3% and 1.2%, respectively. They were followed by pharmaceutical company Sanofi ( SNY ) and lender Banco Santander (SAN), which were off 0.9% and 0.8%, respectively.

The gainers from the UK were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which rose 7% and 4.8%, respectively. They were followed by biopharmaceutical companies NuCana ( NCNA ) and Bicycle Therapeutics ( BCYC ) , which increased 4.1% and 2.4%, respectively.

The decliners from the UK and Ireland were led by biotech company Trinity Biotech ( TRIB ) and cruise line operator Carnival (CUK), which fell 4.7% and 3.3%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and lender Barclays ( BCS ) , which were down 2.2% and 0.9%, respectively.